Literature DB >> 12717246

Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.

John C Cheville1, Christine M Lohse, Horst Zincke, Amy L Weaver, Michael L Blute.   

Abstract

Our objective was to compare cancer-specific survival and to examine associations with outcome among the histologic subtypes of renal cell carcinoma (RCC). We studied 2385 patients whose first surgery between 1970 and 2000 was a radical nephrectomy for sporadic, unilateral RCC. All RCC tumors were classified following the 1997 Union Internationale Contre le Cancer and American Joint Committee on Cancer guidelines. There were 1985 (83.2%) patients with clear cell, 270 (11.3%) with papillary, 102 (4.3%) with chromophobe, 6 (0.3%) with collecting duct, 5 (0.3%) with purely sarcomatoid RCC and no underlying histologic subtype, and 17 (0.7%) with RCC, not otherwise specified. Cancer-specific survival rates at 5 years for patients with clear cell, papillary, and chromophobe RCC were 68.9%, 87.4%, and 86.7%, respectively. Patients with clear cell RCC had a poorer prognosis compared with patients with papillary and chromophobe RCC (p <0.001). This difference in outcome was observed even after stratifying by 1997 tumor stage and nuclear grade. There was no significant difference in cancer-specific survival between patients with papillary and chromophobe RCC (p = 0.918). The 1997 TNM stage, tumor size, presence of a sarcomatoid component, and nuclear grade were significantly associated with death from clear cell, papillary, and chromophobe RCC. Histologic tumor necrosis was significantly associated with death from clear cell and chromophobe RCC, but not with death from papillary RCC. Our results demonstrate that there are significant differences in outcome and associations with outcome for the different histologic subtypes of RCC, highlighting the need for accurate subtyping.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717246     DOI: 10.1097/00000478-200305000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  265 in total

1.  Prediction of site-specific metastases in surgically treated nonmetastatic renal cell cancer. Changes of follow-up protocol.

Authors:  I Frank; H Zincke
Journal:  Urologe A       Date:  2004-09       Impact factor: 0.639

Review 2.  Circulating biomarkers in advanced renal cell carcinoma: clinical applications.

Authors:  Maria Hernandez-Yanez; John V Heymach; Amado J Zurita
Journal:  Curr Oncol Rep       Date:  2012-06       Impact factor: 5.075

3.  Multi-colour FISH on preoperative renal tumour biopsies to confirm the diagnosis of uncertain renal masses.

Authors:  Aliaksei Chyhrai; Jimsgene Sanjmyatav; Mieczyslaw Gajda; Olaf Reichelt; Heiko Wunderlich; Thomas Steiner; Enis Tanović; Kerstin Junker
Journal:  World J Urol       Date:  2010-06       Impact factor: 4.226

Review 4.  Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).

Authors:  Juan I Martínez-Salamanca; Estefania Linares; Javier González; Roberto Bertini; Joaquín A Carballido; Thomas Chromecki; Gaetano Ciancio; Sia Daneshmand; Christopher P Evans; Paolo Gontero; Axel Haferkamp; Markus Hohenfellner; William C Huang; Theresa M Koppie; Viraj A Master; Rayan Matloob; James M McKiernan; Carrie M Mlynarczyk; Francesco Montorsi; Hao G Nguyen; Giacomo Novara; Sascha Pahernik; Juan Palou; Raj S Pruthi; Krishna Ramaswamy; Oscar Rodriguez Faba; Paul Russo; Shahrokh F Shariat; Martin Spahn; Carlo Terrone; Derya Tilki; Daniel Vergho; Eric M Wallen; Evanguelos Xylinas; Richard Zigeuner; John A Libertino
Journal:  Curr Urol Rep       Date:  2014-05       Impact factor: 3.092

5.  FOXM1-Activated LINC01094 Promotes Clear Cell Renal Cell Carcinoma Development via MicroRNA 224-5p/CHSY1.

Authors:  Yufeng Jiang; Haimin Zhang; Wei Li; Yang Yan; Xudong Yao; Wenyu Gu
Journal:  Mol Cell Biol       Date:  2020-01-16       Impact factor: 4.272

Review 6.  [Noninvasive phenotyping of renal tumors-current state of the art].

Authors:  Hubert Stefan Bickel
Journal:  Radiologe       Date:  2018-10       Impact factor: 0.635

7.  Renal tumor causing haematuria and sepsis.

Authors:  Attila Szendrôi; András Rusz; Eszter Székely; Péter Riesz; Zsolt Kelemen
Journal:  Pathol Oncol Res       Date:  2003-12-22       Impact factor: 3.201

Review 8.  Prognostic impact of PD-1 and its ligands in renal cell carcinoma.

Authors:  Franziska Erlmeier; Wilko Weichert; Andres Jan Schrader; Michael Autenrieth; Arndt Hartmann; Sandra Steffens; Philipp Ivanyi
Journal:  Med Oncol       Date:  2017-04-21       Impact factor: 3.064

9.  Grade 4 unclassified renal cell carcinoma with sarcomatoid component expressing S-100 protein. A case report with peculiar diagnostic and therapeutic implications.

Authors:  Gianmaria Miolo; Anthony Ash; Angela Buonadonna; Giovanni Lo Re; Elena Torrisi; Silvia Cervo; Davide Adriano Santeufemia; Alessandro Tuzi; Vincenzo Canzonieri
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

10.  The role of surgery in clinical management of patients with metastatic papillary renal cell carcinoma.

Authors:  Thomas Steiner; Hartmut Kirchner; Michael Siebels; Christian Doehn; Hans Heynemann; Zoltan Varga; Detlef Rohde; Joerg Schubert; Dieter Jocham; Christian Stief; Paolo Fornara; Rainer Hofmann; Stefan Loening; Jan Roigas
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-12       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.